Variant report
Variant | nsv526266 |
---|---|
Chromosome Location | chr6:68930628-68938309 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:68936509..68943149-chr6:68943386..68947943,7 | K562 | blood: | |
2 | chr6:68597558..68600174-chr6:68936484..68938846,3 | K562 | blood: | |
3 | chr6:68937776..68939599-chr6:68941195..68943265,2 | K562 | blood: | |
4 | chr6:68932965..68935508-chr6:68943074..68945551,2 | K562 | blood: | |
5 | chr6:68928154..68930694-chr6:68933230..68935835,2 | K562 | blood: | |
6 | chr6:68933094..68935275-chr6:68937199..68939235,2 | K562 | blood: | |
7 | chr6:68933094..68935275-chr6:68937199..68939235,2 | K562 | blood: | |
8 | chr6:68928154..68930694-chr6:68933230..68935835,2 | K562 | blood: | |
9 | chr6:68587425..68594562-chr6:68930728..68938009,10 | K562 | blood: | |
10 | chr6:68590833..68592511-chr6:68938075..68940408,2 | K562 | blood: | |
11 | chr6:68595627..68600174-chr6:68934474..68938541,5 | K562 | blood: | |
12 | chr6:68589435..68592511-chr6:68936619..68941410,4 | K562 | blood: | |
13 | chr6:68805183..68807758-chr6:68934984..68937347,2 | K562 | blood: | |
14 | chr6:68642346..68643318-chr6:68935421..68936071,2 | MCF-7 | breast: | |
15 | chr6:68750041..68751555-chr6:68934848..68937816,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AL713998.1-1 | chr6:68936864-68937184 | XLOC_005757 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227706 | chromatin interactions |
DIP2C | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9360322 | chr6:68930628-68930629 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs575921790 | chr6:68930646-68930647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184671096 | chr6:68930659-68930660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557992968 | chr6:68930670-68930671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188570141 | chr6:68930696-68930697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199840089 | chr6:68930710-68930711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368774119 | chr6:68930713-68930714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192221083 | chr6:68930731-68930732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9445980 | chr6:68930738-68930739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573652875 | chr6:68930782-68930783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374108209 | chr6:68930799-68930800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531336652 | chr6:68930821-68930822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115194907 | chr6:68930855-68930856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549643211 | chr6:68930877-68930878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140951362 | chr6:68930901-68930902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184384029 | chr6:68930978-68930979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565130692 | chr6:68930995-68930996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144753214 | chr6:68931033-68931034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146735850 | chr6:68931095-68931096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111489333 | chr6:68931120-68931121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375987694 | chr6:68931134-68931135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567015943 | chr6:68931138-68931139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535554696 | chr6:68931148-68931149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546000351 | chr6:68931149-68931150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370337912 | chr6:68931215-68931216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75404822 | chr6:68931218-68931219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140375445 | chr6:68931280-68931281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569366423 | chr6:68931356-68931357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555994742 | chr6:68932621-68932622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576078554 | chr6:68932681-68932682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541862230 | chr6:68932698-68932699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374555413 | chr6:68932710-68932711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558761288 | chr6:68932810-68932811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572402814 | chr6:68932817-68932818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541352646 | chr6:68932833-68932834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561208601 | chr6:68932880-68932881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529272615 | chr6:68932889-68932890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542965074 | chr6:68932895-68932896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185548933 | chr6:68932916-68932917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553513414 | chr6:68932955-68932956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551594997 | chr6:68932970-68932971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571524505 | chr6:68932983-68932984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527853877 | chr6:68932990-68932991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547780870 | chr6:68933020-68933021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567908134 | chr6:68933035-68933036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9342692 | chr6:68933042-68933043 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs569796672 | chr6:68933060-68933061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538719893 | chr6:68933096-68933097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189960318 | chr6:68933117-68933118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572291044 | chr6:68933136-68933137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:68929000-68931400 | Weak transcription | Aorta | Aorta |
2 | chr6:68932600-68933000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:68932800-68933000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:68932800-68933000 | Enhancers | K562 | blood |
5 | chr6:68933000-68935200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr6:68933000-68935200 | Weak transcription | K562 | blood |
7 | chr6:68933000-68936000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:68935000-68935800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr6:68935000-68936200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr6:68935200-68935400 | Enhancers | K562 | blood |
11 | chr6:68935200-68936000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:68935200-68936400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr6:68935400-68935800 | Weak transcription | K562 | blood |
14 | chr6:68935400-68936400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr6:68935600-68936400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr6:68935600-68936400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr6:68935800-68936200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
18 | chr6:68935800-68936400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
19 | chr6:68935800-68936800 | Enhancers | K562 | blood |
20 | chr6:68936000-68936400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr6:68936200-68936400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
22 | chr6:68936400-68939400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr6:68936400-68939600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
24 | chr6:68936400-68947200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |